US Cancer Detection Decreased Nearly 9 Percent During The First Year Of The COVID-19 Pandemic
Uriel Kim, Siran M. Koroukian, Johnie Rose, Richard S. Hoehn, Bryan T. Carroll
Abstract
We investigated the impact of the COVID-19 pandemic on cancer detection, using data from the Surveillance, Epidemiology, and End Results Program, which recently released data through the first year of the pandemic (2020). Across all cancer sites, cancer incidence fell by 8.7 percent. The most common cancers that experienced the largest disruptions were lung and bronchus, melanoma of the skin, and thyroid cancer.
Topics & Concepts
PandemicCoronavirus disease 2019 (COVID-19)MedicineIncidence (geometry)Lung cancerEpidemiologyCancerSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakThyroid cancerDemographyOncologyInternal medicineVirologyOutbreakDiseaseSociologyPhysicsInfectious disease (medical specialty)OpticsCOVID-19 and healthcare impactsGlobal Cancer Incidence and ScreeningEconomic and Financial Impacts of Cancer